Riskpilot← Back to searchSign inGet full accessBIOREN A/S
A/SActiveCVR 16396273Vognserup 6Wholesale of solid, liquid and gaseous fuels and related products · NACE 4681Est. 19922 employees
Revenue 2025
DKK -64K
+1108% vs 2024
EBITDA margin
248.3%
-21% vs 2024
Equity ratio
100.0%
Financial strength
Net profit 2025
DKK -257K
-257% vs 2024
| Revenue | DKK -64K | +1108% |
| EBITDA | DKK -158K | -21% |
| Net profit | DKK -257K | -257% |
| Total assets | DKK 1,1M | -25% |
| Equity | DKK 1,1M | -19% |
| Employees | 2 | — |
Legal name
BIOREN A/S
CVR number
16396273
Legal form
Aktieselskab
NACE code
4681 · Wholesale of solid, liquid and gaseous fuels and related products
Founded
1. oktober 1992
Share capital
DKK 500.000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren eller af to bestyrelsesmedlemmer i forening.
Company purpose
Selskabets formål er at drive fabrikation og handelsvirksomhed.
Address
Vognserup 6
Phone
+4559264448
Email
bioren@bioren.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 73 | 18 | 90 | 169 | 134 | 204 | 79 | 96 | 40 | 169 | 271 | 36 | -5 | -64 |
| Staff expenses | -17 | -15 | -3 | -26 | -11 | -4 | -4 | -7 | -12 | -4 | -50 | -120 | -120 | -90 |
| EBITDA | 56 | 3 | 87 | 143 | 122 | 200 | 75 | 84 | 24 | 165 | 205 | -92 | -131 | -158 |
| Depreciation & amort. | -53 | -56 | -66 | -49 | -54 | -48 | -44 | -44 | -44 | -34 | -26 | -29 | -19 | -19 |
| EBIT | 3 | -52 | 21 | 94 | 68 | 153 | 31 | 40 | -20 | 131 | 180 | -121 | -150 | -176 |
| Net financials | 61 | -9 | -8 | -17 | 28 | 47 | 17 | -48 | 148 | -162 | -295 | 93 | 326 | -92 |
| Profit before tax | 64 | -61 | 13 | 137 | 141 | 200 | 48 | -8 | 128 | -31 | -115 | -28 | 176 | -269 |
| Tax | -0 | -0 | -0 | 34 | 36 | 47 | 13 | -1 | 30 | -7 | -1 | -5 | 12 | -12 |
| Net profit | 64 | -61 | 13 | 104 | 105 | 153 | 35 | -7 | 98 | -24 | -114 | -23 | 164 | -257 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1.127 | 1.159 | 938 | 1.037 | 1.150 | 1.347 | 1.271 | 1.410 | 1.357 | 1.310 | 1.390 | 1.215 | 1.440 | 1.075 |
| Equity | 887 | 827 | 840 | 944 | 1.049 | 1.202 | 1.237 | 1.230 | 1.328 | 1.304 | 1.191 | 1.168 | 1.332 | 1.075 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 240 | 332 | 97 | 67 | 77 | 124 | 17 | 168 | 19 | 3 | 195 | 47 | 96 | 0 |
| Total debt | 240 | 332 | 97 | 67 | 77 | 124 | 17 | 168 | 19 | 3 | 195 | 47 | 96 | 0 |
EBITDA margin
-15777800.0%
This company
15.8%
Market median
-99859594% vs market
20122025
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20122025
Return on equity
-23.9%
This company
18.4%
Market median
-230% vs market
20122025
Net profit margin
-25667200.0%
This company
8.1%
Market median
-316879112% vs market
20122025
Asset turnover
-0.06×
This company
1.12×
Market median
-105% vs market
20122025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via CVR / Virk · Period 2019-10-01 – 2020-09-30
- Annual report 2019Filed via CVR / Virk · Period 2018-10-01 – 2019-09-30
- Annual report 2018Filed via CVR / Virk · Period 2017-10-01 – 2018-09-30
- Annual report 2017Filed via CVR / Virk · Period 2016-10-01 – 2017-09-30
- Annual report 2016Filed via CVR / Virk · Period 2015-10-01 – 2016-09-30
- Annual report 2015Filed via CVR / Virk · Period 2014-10-01 – 2015-09-30
- Annual report 2014Filed via CVR / Virk · Period 2013-10-01 – 2014-09-30
- Annual report 2013Filed via CVR / Virk · Period 2012-10-01 – 2013-09-30
- Annual report 2012Filed via CVR / Virk · Period 2011-10-01 – 2012-09-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AR | Audit | 1992 | — | — |
MM Founder | Founder | 1992 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2006 | — | — | |
| Board of Directors | 2011 | — | — | |
| Board of Directors | 1992 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 1992 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BIOREN A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Asnæs Revisorinteressentskab | Audit | 0 companies |
| Maren Mille Høj | Founder | 0 companies |
| Martin Peter Høj | Board of Directors | 0 companies |
| Mette Louise Høj | Board of Directors | 0 companies |
| Hans-Jørgen Nilaus Rasmussen | Board of Directors | 0 companies |